Product
Treatment administration
1 clinical trial
2 indications
Indication
COVID-19Indication
Coronavirus InfectionClinical trial
A Phase IIb, Double Blind, Placebo-controlled Clinical Study Designed to Evaluate the Effect of CimetrA in Patients Diagnosed With COVID-19Status: Completed, Estimated PCD: 2023-01-21